Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patients. 1985

A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin

Using a highly specific and sensitive radioimmunoassay for dynorphin(1-8) (D 1-8), and a singly blind test design, we measured D(1-8) immunoreactivity (ir D 1-8) in CSF of 35 first break cases of acute schizophrenic patients. All patients were free of psychotropic medication for at least one week before the study. Another 31 neurological patients suffered from cervical arthrosis, tumor, myelopathy etc. were studied as controls. The ir D(1-8) in CSF of schizophrenic patients were significantly lower than that of controls (91.8 +/- 5.6, means +/- S.E.M., and 131.9 +/- 6.8 fmol/ml CSF respectively, p less than 0.001).

UI MeSH Term Description Entries
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004399 Dynorphins A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. Dynorphin,Dynorphin (1-17),Dynorphin A,Dynorphin A (1-17)
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
February 1991, Biological psychiatry,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
January 1988, Life sciences,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
April 1989, Neuropeptides,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
May 1992, Biological psychiatry,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
January 1986, Psychiatry research,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
December 1991, Brain research,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
January 1982, Advances in biochemical psychopharmacology,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
April 1982, Brain research,
A Z Zhang, and G Z Zhou, and G F Xi, and N F Gu, and Z Y Xia, and J L Yao, and J K Chang, and R Webber, and S Potkin
November 1982, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!